On November 28, 2025, Venus Medtech (Hangzhou) Inc. (2500) convened an Extraordinary General Meeting (EGM) at its facility in Hangzhou, the PRC. The total number of issued shares as of the date of the EGM was 441,011,443, with 3,114,000 repurchased H shares pending cancellation and not exercisable at the meeting. The number of shares entitled to vote was therefore 437,897,443.

Shareholders and authorized proxies representing 143,151,232 shares, or approximately 32.46% of the company’s issued share capital, attended the EGM. The resolution regarding the Disposal Agreement was unanimously approved as an ordinary resolution, receiving 100% votes in favor. No shareholders were required to abstain or voted against the resolution. The company confirms that the voting process complied fully with relevant laws and regulations, and the resolution passed is valid.